Big Moving Stock keep track of the biggest moving stocks in the market.
The Hot Industries
Auto Parts Stores 2
Air Delivery & Freight Services 1
The Hot Sectors
JNJ Johnson & Johnson
Johnson & Johnson, together with its subsidiaries, is engaged in the research and development, manufacture, and sale of various products in the health care field worldwide. The company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. The Consumer segment offers a range of products used in the baby care, skin care, oral care, wound care, and womens health fields, as well as nutritionals, over-the-counter pharmaceutical products, and wellness and prevention platforms under the JOHNSONS, AVEENO, CLEAN & CLEAR, DABAO, JOHNSONS Adult, LUBRIDERM, NEUTROGENA, RoC, VENDÔME, LISTERINE, BAND-AID, NEOSPORIN, STAYFREE, CAREFREE, o.b. tampon, SPLENDA, TYLENOL, SUDAFED, ZYRTEC, MOTRIN IB, and PEPCID brand names. This segment markets its products to the general public, as well as to retail outlets and distributors. The Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, cardiovascular, contraceptive, gastrointestinal, hematology, immunology, infectious diseases, metabolic, neurology, oncology, pain management, thrombosis, and vaccines. This segment distributes its products directly to retailers, wholesalers, and health care professionals for prescription use. The Medical Devices and Diagnostics segment offers various products to treat cardiovascular disease; orthopaedic and neurological products; blood glucose monitoring and insulin delivery products; general surgery, biosurgical, and energy products; professional diagnostic products; infection prevention products; and disposable contact lenses. This segment distributes its products to wholesalers, hospitals, and retailers, used principally in the professional fields by physicians, nurses, hospitals, and clinics. Johnson & Johnson was founded in 1885 and is based in New Brunswick, New Jersey.
Stock Market News for October 31, 201431 Oct 2014, 7:34 amBenchmarks ended in the green zone on Thursday, banking on encouraging third quarter GDP numbers and upbeat quarterly results
Johnson & Johnson Fairly Valued - I Will Bet on It30 Oct 2014, 9:59 amBy ovenerio. Read more » » Check out Paul Tudor Jones Stock Picks » Download GuruFolio Report of Paul Tudor Jones (Updated on 10/30/2014) , Check out John Rogers Stock Picks » Download GuruFolio Report of John Rogers (Updated on 10/30/2014) , Check out Richard Pzena Stock Picks » Download GuruFolio Report of Richard Pzena (Updated on 10/30/2014) , Check out Sarah K Stock Picks » Download ...
Lakeland (LAKE) Stock Soars 30% on Hazmat Suit Sales, Ebola Panic30 Oct 2014, 8:20 amHazmat suit maker Lakeland industries is soaring again today as sales have been great thanks to the Ebola virus.
Vertex Pharmaceuticals Posts Narrower-than-Expected Loss - Analyst Blog29 Oct 2014, 12:34 pmVertex Pharmaceuticals Posts Narrower-than-Expected Loss - Analyst Blog
One Put, One Call Option To Know About for Johnson & Johnson27 Oct 2014, 11:01 amConsistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Johnson & Johnson (NYSE: JNJ). So this week we highlight one interesting put contract, and one interesting call contract, from the December expiration for JNJ.
Johnson & Johnson (JNJ) Stock Rises Today Following Texas Lawsuit Dismissal24 Oct 2014, 8:44 amNEW YORK (TheStreet) -- Johnson & Johnson shares are up 0.3% to $102.94 on Friday after the consumer products manufacturer won a lawsuit brought against it by a Texas woman who sought damages for what she claimed was a faulty metal on metal hip implant that poisoned her. The jury unanimously ruled in favor of Johnson & Johnson finding that the product isn't defective and that the company had ...
Why Johnson & Johnson (JNJ) Stock Is Higher Today22 Oct 2014, 6:13 amNEW YORK (TheStreet) -- Shares of Johnson & Johnsona are up 1.61% to $101.98 in pre-market trade after it was reported this morning that the company plans to have 250,000 doses of an experimental Ebolaavaccine ready for use in clinical trials in May, potentially putting it ahead of GlaxoSmithKline ain the race to protect against the virus that has killed thousands of people in West Africa ...
Why Johnson & Johnson (JNJ) Stock Is Up Today15 Oct 2014, 8:59 amNEW YORK (TheStreet) -- Johnson & Johnson ashares are higher by 0.45% to $97.44 after the company reported third quarter net income of $4.7 billion, or $1.66 per diluted share, compared to $2.9 billion, or $1.04 per diluted share, for the same period a year ago. Third quarterasales were $18.5 billion compared to $17.6 billion for the same quarter in 2013, the company said. J&J, which makes a ...
Interesting October Stock Options for Johnson & Johnson13 Oct 2014, 10:59 amConsistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Johnson & Johnson (NYSE: JNJ). So this week we highlight one interesting put contract, and one interesting call contract, from the October expiration for JNJ.
Why Johnson & Johnson (JNJ) Stock Is Climbing Today10 Oct 2014, 8:00 amNEW YORK (TheStreet) -- Shares of Johnsona& Johnsona are higher by 0.14% to $102.22 in early market tradingaafter analysts ataCredit Suisseaupgraded the consumer health companyato "neutral"afrom "underperform" this morning. The health products giantais currently covered by 22 Wall Street analysts, and has an average price target of $109.23. Johnson & Johnson isaone of the biggest health care ...